Sonographic Features of Rectus Femoris Muscle in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Their Correlation with Body Composition Parameters and Muscle Strength: Results of a Single-Center Cross-Sectional Study

被引:0
|
作者
Sheptulina, Anna F. [1 ]
Yafarova, Adel A. [1 ]
Mamutova, Elvira M. [1 ]
Drapkina, Oxana M. [1 ,2 ]
机构
[1] Natl Med Res Ctr Therapy & Prevent Med, Dept Fundamental & Appl Aspects Obes, Moscow 101990, Russia
[2] AI Evdokimov Moscow State Univ Med & Dent, Dept Therapy & Prevent Med, Moscow 127473, Russia
基金
俄罗斯科学基金会;
关键词
ultrasound; skeletal muscles; dual-energy X-ray absorptiometry; bioimpedance analysis; metabolic dysfunction-associated steatotic liver disease; BONE-MINERAL DENSITY; PHYSICAL-ACTIVITY; SARCOPENIC OBESITY; OLDER-ADULTS; ULTRASOUND; DISCORDANCE; RELIABILITY; DIAGNOSIS; ELASTOGRAPHY; DEFINITION;
D O I
10.3390/biomedicines12081684
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to describe sonographic features of rectus femoris muscle (RFM) in patients with metabolic dysfunction-associated fatty liver disease (MASLD) and their correlation with body composition parameters and muscle strength. A total of 67 patients with MASLD underwent dual-energy X-ray absorptiometry (DEXA), bioimpedance analysis (BIA), muscle strength measurement (grip strength [GS] and chair stand test [CST]), and ultrasound (US) investigation of the RFM in the dominant thigh using a 4 to 18 MHz linear probe. MASLD patients exhibited increased RFM echogenicity, possibly due to fatty infiltration. We confirmed that the greater the subcutaneous fat thickness, the smaller was the muscle mass (p < 0.001), and the lower was the muscle strength (p < 0.001 for GS and p = 0.002 for CST). On the contrary, the greater the anteroposterior diameter (APD) of RFM, the higher was the muscle mass (p < 0.001), and the greater was the muscle strength (p < 0.001 for GS and p = 0.007 for CST). In addition, APD of the RFM and stiffness of RFM exhibited direct correlation with bone mineral density values of the lumbar spine (p = 0.005 for both GS and CST). We concluded that US investigation of the RFM in the dominant thigh can be helpful in identifying MASLD patients at a high risk of musculoskeletal disorders given repeated point-of-care clinical evaluations.
引用
收藏
页数:19
相关论文
共 50 条
  • [11] Appendicular skeletal muscle mass is associated with metabolic dysfunction-associated steatotic liver disease severity in young men: a cross-sectional and longitudinal study
    Lee, Jaejun
    So, Jinson
    Han, Chang In
    Yang, Hyun
    Sung, Pil Soo
    Bae, Si Hyun
    Song, Do Seon
    HEPATOLOGY INTERNATIONAL, 2025, 19 (01) : 181 - 190
  • [12] Metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease from clinical to pathological characteristics: a multi-center cross-sectional study in real world
    Li, Yan
    Dai, Changyong
    Ruan, Yuhua
    Yang, Haiqing
    Zeng, Huang
    Huang, Rui
    Wang, Jialu
    Dai, Mingjia
    Hao, Jungui
    Wang, Liping
    Li, Jie
    Yan, Xuebing
    Lu, Zhonghua
    Ji, Fang
    POSTGRADUATE MEDICAL JOURNAL, 2024, 100 (1183) : 319 - 326
  • [13] METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH CERVICAL STROMAL INVOLVEMENT IN PATIENTS WITH ENDOMETRIAL CANCER: A CROSS-SECTIONAL STUDY IN SOUTH CHINA
    Lin, Xite
    Chen, Chunxia
    Jiang, Tingting
    Ma, Jincheng
    Huang, Lixiang
    Huang, Leyi
    Lei, Huifang
    Tong, Yao
    Huang, Guanxiang
    Mao, Xiaodan
    Sun, Pengming
    ANTICANCER RESEARCH, 2023, 43 (07) : 3370 - 3371
  • [14] The association between the dietary index for gut microbiota and metabolic dysfunction-associated fatty liver disease: a cross-sectional study
    Zheng, Yangyang
    Hou, Jinhui
    Guo, Shiqi
    Song, Jinghai
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01):
  • [15] Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study
    Yanli Zhang
    Zhang Xia
    Xueli Cai
    Xin Su
    Aoming Jin
    Lerong Mei
    Jing Jing
    Suying Wang
    Xia Meng
    Shan Li
    Mengxing Wang
    Tiemin Wei
    Yongjun Wang
    Yan He
    Yuesong Pan
    Cardiovascular Diabetology, 22
  • [16] Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study
    Zhang, Yanli
    Xia, Zhang
    Cai, Xueli
    Su, Xin
    Jin, Aoming
    Mei, Lerong
    Jing, Jing
    Wang, Suying
    Meng, Xia
    Li, Shan
    Wang, Mengxing
    Wei, Tiemin
    Wang, Yongjun
    He, Yan
    Pan, Yuesong
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [17] Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: A cross-sectional study using FibroScan
    Yesil, Ezgi Ersoy
    Yilmaz, Yusuf
    Yesil, Atakan
    Mese, Meral
    Kaya, Eda
    Bakir, Elif Ari
    HEPATOLOGY FORUM, 2023, 4 (01): : 14 - 18
  • [18] Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study
    Tateda, Tetsuyuki
    Iino, Chikara
    Sasada, Takafumi
    Sato, Satoshi
    Igarashi, Go
    Kawaguchi, Shogo
    Mikami, Kenichiro
    Endo, Tetsu
    Sawada, Kaori
    Mikami, Tatsuya
    Fukuda, Shinsaku
    Nakaji, Shigeyuki
    Sakuraba, Hirotake
    PLOS ONE, 2022, 17 (11):
  • [19] An Observational and Cross-Sectional Study of the Prevalence of Breast Lesions and Metabolic Dysfunction-Associated Fatty Liver Disease and their Relationship in China
    Li, Shu
    Xu, Zhou
    Li, Hao
    Tang, Juan
    Liang, Xin-yu
    Tian, Shen
    Wu, Juan
    Li, Xin
    Liu, Zi-li
    Xiao, Jun
    Chen, Yu-ling
    Wei, Jia-ying
    Ma, Chen-yu
    Wu, Kai-nan
    Ran, Liang
    Kong, Ling-quan
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022, 31 (01) : 31 - 39
  • [20] Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study
    Sung, Ki-Chul
    Yoo, Tae Kyung
    Lee, Mi Yeon
    Byrne, Christopher D.
    Zheng, Ming-Hua
    Targher, Giovanni
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (03) : 482 - 491